Our mission is to ensure the generation of accurate and precise findings.

Contact Info Ta-134/A, Gulshan Badda Link 61383766284 noreply@envato.com
GET UPDATE

Please enter subscribe form shortcode

MetaboAD: metabolomics-based approach for a mentally healthier society

Our highly multidisciplinary team aims to develop early diagnostic biomarkers in Alzheimer’s disease

About Us

About MetaboAD

A new consortium of 6 international and multidisciplinary partners from the academia and small enterprises aim to tackle the unmet need of novel druggable biomarkers in early Alzheimer’s disease.

  • Transnational cohorts from 3 countries
  • Analysis of prodormal and early Alzheimer’s samples
  • Metabolomics and glyconomics
  • Drugability assessment

6

Partners

5

Countries

9.7

Million dementia cases in Europe

55

Million dementia cases globally

10

Million new cases per year

1.3

trillion USD/year cost of dementia globally

News & publications

Recently added